Paper Details 
Original Abstract of the Article :
At several out-of-hours services primary care, a single dose of ondansetron was compared with standard care (oral rehydration solution (ORS)) in young children with gastroenteritis and persistent vomiting. Although vomiting decreased more often in the ondansetron group compared to the control group ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/35499602

データ提供:米国国立医学図書館(NLM)

Ondansetron for Vomiting in Young Children: A Desert of Uncertainty

Gastroenteritis is a common ailment in young children, often accompanied by persistent vomiting. This study investigates the efficacy of ondansetron, an anti-emetic medication, in treating vomiting in young children with gastroenteritis. The researchers compared a single dose of ondansetron to standard care (oral rehydration solution (ORS)) in children with persistent vomiting.

Ondansetron's Limited Benefits: A Desert Mirage?

The study found that ondansetron did not significantly reduce the need for ORS or hospital referrals despite a slight reduction in vomiting in the initial hours. The authors also raise concerns about potential adverse effects, such as diarrhea, associated with ondansetron use. These findings question the clinical benefit of ondansetron in this context.

Navigating the Desert of Childhood Vomiting

The desert of childhood vomiting can be a challenging experience for both children and parents. While ondansetron may offer some temporary relief, this study suggests that its benefits may be limited. Consult with a healthcare provider to make informed decisions about treatment options.

Dr. Camel's Conclusion

This study delves into the desert of ondansetron's efficacy in treating vomiting in young children. The findings suggest that its benefits may be limited and may not outweigh potential risks. As we navigate the complexities of childhood illnesses, it's essential to rely on evidence-based practices and make informed decisions about treatment options. Remember, like a camel navigating a dry and arid landscape, we must make wise choices to protect our health and well-being.

Date :
  1. Date Completed 2022-05-04
  2. Date Revised 2022-05-05
Further Info :

Pubmed ID

35499602

DOI: Digital Object Identifier

35499602

Related Literature

SNS
PICO Info
in preparation
Languages

Dutch

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.